Recent trends show that insurance companies are encountering significant challenges in the current market landscape.
In a worrying trend, several companies have publicly stated their intentions to either withdraw or lower their earnings guidance for the year. Notable examples include:
- On Tuesday, Oscar Health revealed its expectation of incurring an operational loss ranging from $200 million to $300 million for the year, a stark contrast to their earlier forecast of earnings between $225 million and $275 million.
- Last week, Elevance Health announced a downward adjustment of its outlook for adjusted earnings per share, now projecting approximately $30 for the year, down from $34.15.
- On Thursday, Molina Healthcare revised its expectations for full-year 2025 adjusted earnings to $19 per diluted share, a drop from the previously predicted range of $21.50 to $22.50. This marks the second adjustment they’ve made this month.
- Earlier this month, Centene announced the withdrawal of its 2025 GAAP and adjusted diluted earnings per share guidance.
What factors are contributing to the dismal financial outlook for so many insurance companies?
Experts indicate that much of the turmoil is linked to unexpectedly high levels of utilization, especially within the individual market. Patients are increasingly utilizing costly weight loss drugs, seeking out behavioral health services, and accessing other medical services at rates that exceed past expectations. These trends have led to a significant increase in claims that insurers must manage.
Moreover, uncertainty looms on the horizon for both insurers and their members, particularly with looming Medicaid cuts and the impending expiration of the ACA enhanced premium tax credits, both of which are anticipated to escalate costs and result in many individuals losing coverage.
Understanding the Current Challenges Facing the Insurance Sector
The individual market appears to be one of the most significant areas of concern for many insurers at this moment, with higher-than-expected utilization rates leading to increased costs, according to Ari Gottlieb, principal of the consulting firm A2 Strategy Corp.
“A pervasive issue is the fact that the business has been underpriced,” he stated during an interview. “We’re observing an uptick in utilization. Individuals holding individual plans are making greater use of them: from weight loss medications to high-cost specialty services and behavioral health care, the demand is rising. Insurers did not anticipate this surge.”
He further noted that many more individuals were placed on individual plans due to the Medicaid redetermination process, where individuals were reassessed for eligibility, resulting in a higher acuity and utilization rate.
During the company’s earnings call, Elevance CEO Gail K. Boudreaux highlighted these specific challenges, indicating that the company’s adjusted earnings were reflective of “elevated medical cost trends across ACA and slower-than-anticipated Medicaid rate alignment.”
Essentially, during the pandemic, the eligibility redeterminations for Medicaid were paused, allowing numerous individuals to remain enrolled despite not accessing care. With the resumption of redeterminations, many low-utilization members have been removed from the rolls, yet states continue to rely on outdated utilization data to set reimbursement rates for plans. Consequently, Medicaid plans are receiving lower payments relative to the heightened needs of their current enrollees, according to Gottlieb.
Oscar Health, which focuses on individual and family plans, is also grappling with increased utilization and acuity. In its recent announcement, the company projected a medical loss ratio of 86% to 87% alongside heightened risk scores within the ACA Marketplace.
Similarly, Molina, which has a substantial presence in the individual market, stated that its revised guidance is largely attributed to its performance in the Marketplace.
“Our second quarter results and adjusted full-year outlook reflect a challenging medical cost trend environment,” commented Joseph Zubretsky, president and CEO, in a statement. “The earnings pressure we are currently experiencing arises from what we believe to be a temporary misalignment between premium rates and the escalating medical cost trends.”
Another significant hurdle for insurers is the increased focus on combating fraud, as noted by Hal Andrews, president and CEO of Trilliant Health. He pointed out that the U.S. Senate recently targeted a loophole that enabled some individuals to be dual enrolled in Medicare Advantage while also receiving coverage from the Veterans Health Administration. This loophole allowed healthcare insurers to bill Medicare for veterans’ care, even though they were receiving treatment through the VHA. Recently, lawmakers introduced a bill aimed at allowing the VA to charge private health insurers within the Medicare Advantage framework for the medical care provided to their members.
Additionally, the Centers for Medicare & Medicaid Services (CMS) recently estimated that approximately 2.8 million Americans are enrolled in multiple Medicaid and ACA exchange plans, resulting in the government incurring duplicate costs for health coverage. CMS is collaborating with states to resolve these issues of duplicate enrollment by providing states with lists of individuals enrolled in Medicaid across various states and requesting them to verify eligibility.
“Even though many individuals are primarily receiving their healthcare from one plan, the government is subsidizing premiums for multiple plans,” Andrews explained in an email. “It’s akin to a gym like Planet Fitness having members who pay their monthly fees without actually utilizing the facilities.”
“However, for insurers, this situation is evolving, and as a result, they are poised to lose millions of these members. This dynamic is prompting many insurers to withdraw or adjust their earnings guidance,” he added, referring to the recent policy shifts from CMS and Congress.
The recent earnings cuts and withdrawals echo a similar announcement made by UnitedHealth Group in May. The healthcare giant suspended its 2025 outlook and replaced Andrew Witty as CEO with Stephen J. Hemsley, who previously served as the company’s CEO from 2006 to 2017.
However, it is important to note that while several insurers have attributed their recent challenges to the individual market, UnitedHealth Group presents a somewhat different narrative, as pointed out by Gottlieb. The company suspended its earnings guidance due to increased utilization in Medicare Advantage, while other insurers have reported that their MA operations are performing as anticipated.
Anticipating Future Trends in the Insurance Industry
The recent revisions in earnings guidance are indicative of a broader issue: the increasing unaffordability of healthcare within the United States, according to one healthcare expert.
“My interpretation is that we are facing serious challenges regarding pricing. There are potential revenue concerns, and the industry seems uncertain about viable solutions. The strategy appears to be to withdraw guidance while they assess the situation,” stated Dr. Robert Pearl, former CEO of the Permanente Medical Group and current professor at both Stanford University School of Medicine and the Stanford Graduate School of Business. “I don’t perceive a plethora of solutions, as I believe they cannot increase rates sufficiently to cover costs, nor can they reduce expenses as much as desired to maintain their pricing.”
Pearl highlighted the numerous impending challenges for insurers, including the impending Medicaid cuts and the expiration of the ACA enhanced premium tax credits at the end of the year, both of which are expected to cause a substantial rise in premiums. Elevance’s CFO, Mark Bradley Kaye, noted during the earnings call that the reconciliation bill and the expiration of enhanced subsidies could “present near-term enrollment pressures and further shifts in the risk pool.”
Gottlieb concurred that the challenges facing the industry are likely to persist, indicating that the upcoming quarter and year for the individual market could be particularly strenuous, with potential for an even harsher situation next year.
Another industry expert described the guidance cuts as a “wake-up call” for the sector, emphasizing the necessity for quicker adaptation.
“I believe that several strategies could assist in reversing these trends, including improving the speed and utility of data, ensuring access to current information on costs, claims, and patient trends, so that insurers aren’t waiting extended periods to identify issues or make necessary changes, and fostering connectivity between disparate systems that typically do not communicate with one another,” suggested Esteban Lopez, partner at the consulting firm West Monroe.
For more of the latest updates on litigation, regulation, deals, and trends in financial services, consider signing up for Finance Docket, a collaboration between Breaking Media publications Above the Law and Dealbreaker.
